)
)
CollPlant Biotechnologies Investor Relations Material
Latest events
Q3 2024
CollPlant Biotechnologies
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from CollPlant Biotechnologies Ltd
Access all reports
CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine company focused on developing and commercializing products for tissue regeneration and organ manufacturing. The company utilizes its proprietary plant-based recombinant human collagen (rhCollagen) technology to create products that address unmet medical needs in various sectors, including wound care, orthopedics, and 3D bioprinting of tissues and organs. Key offerings include bioinks for 3D printing, wound care products, and orthobiologics. The company collaborates with industry partners to advance its innovative solutions and expand its market presence. The company is headquartered in Rehovot, Israel, and its shares are listed on the NASDAQ.
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
CLGN
Country
🇺🇸 United States